Barrick Gold Corp vs TransMedics Group Inc — how do they compare? Barrick Gold Corp trades at $40.66 (market cap $68.49B), while TransMedics Group Inc trades at $89.69 (market cap $3.07B). The key difference: Barrick Gold Corp is far larger — about 22.3× TransMedics Group Inc's market cap, and Barrick Gold Corp pays a 1.71% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| B | TMDX | |
|---|---|---|
Market Cap | $68.49B | $3.07B |
Sector | Basic Materials | Technology |
52-Week High | $52.97 | $150.42 |
52-Week Low | $23.50 | $61.99 |
Enterprise Value | $66.08B | $3.46B |
Dividend Yield | 1.71% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TMDX trades at $83.89, up 4.59% today, with a bullish technical signal from moving averages and strong support at $81. The company reported a Q2 2026 earnings miss ($0.44 actual vs. $0.50 expected) but beat revenue expectations, with 2025 net income at $190.29M. Analyst consensus is a Buy with a $99.57 price target, though recent news highlights a legal investigation into fiduciary duties.
Outlook remains positive due to raised revenue guidance and institutional interest, but risks include earnings volatility, margin pressure, and legal scrutiny. The stock's valuation multiples suggest growth expectations, yet execution on cost control and international expansion will be critical for sustained upside.
Trailing returns across standard periods
Latest headlines on both assets
Barrick Gold Corp is one of the world's largest gold producers, operating mines in North America, South America, Australia, and Africa. The company segments consist of nine gold mines namely Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, and Bulyanhulu. It generates maximum revenue from the Carlin mine segment. Geographically, it derives a majority of revenue from the United States.
Read more on B →TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →